| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Difluoromethylornithine1
Department of Physiology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania [A. E. P., R. M.]; and Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama [J. A. S.]
L1210 cells were selected for resistance to the ornithine decarboxylase (ODC) inhibitor,
-difluromethylornithine. When grown in the absence of the inhibitor, these cells possessed very high ornithine decarboxylase levels. These represented about 1 part in 300 of the soluble protein, which is several hundred times greater than the maximal value found in the original L1210 cells. The resistant cells contained at least 100-fold higher levels of ODC mRNA but the half-life of ODC (about 45 min) was not altered significantly. The resistant cells had much higher putrescine and cadaverine levels than control cells, but there was no significant difference in cellular spermidine or spermine content or in production of 5'-methylthioadenosine, which is a measure of polyamine synthesis. Addition of putrescine to the control or resistant cells had no effect on their content of spermidine and spermine but addition of decarboxylated S-adenosylmethionine increased the content of spermidine and spermine. These results indicate that ornithine decarboxylase is not the rate-limiting step in polyamine synthesis in these L1210 cells.
The growth of the
-difluoromethylornithine-resistant L1210 cells was inhibited when their ability to synthesize spermidine and spermine was blocked by the addition of the S-adenosylmethionine decarboxylase inhibitor, 5'-deoxy-5'-[N-methyl-N-(3-hydrazinopropyl)]aminoadenosine. Treatment with this compound produced a reduction of more than 85% in the production of 5'-methylthioadenosine and led to a large increase in the content of putrescine and a substantial decline in the content of spermidine and spermine. These results indicate the potential value of S-adenosylmethionine decarboxylase inhibitors as therapeutic agents in conditions where ODC inhibitors are ineffective.
1 This work was supported by Grants CA-18138, CA-37606, GM-26290, and NO1-AI-42555 from NIH.
2 To whom requests for reprints should be addressed, at Department of Physiology, Milton S. Hershey Medical Center, Pennsylvania State University, P. O. Box 850, Hershey, PA 17033.
Received 11/30/87. Revised 2/ 8/88. Accepted 2/16/88.
This article has been cited by other articles:
![]() |
M. J. Mayer and A. J. Michael Polyamine Homeostasis in Transgenic Plants Overexpressing Ornithine Decarboxylase Includes Ornithine Limitation J. Biochem., November 1, 2003; 134(5): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soulet and S. Rivest Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system J. Cell Biol., July 21, 2003; 162(2): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, S. Kim, Y. Yano, S. Yamamoto, and S. Fukushima Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine Carcinogenesis, February 1, 2000; 21(2): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xie, R. J. Gillies, and E. W. Gerner Characterization of a Diamine Exporter in Chinese Hamster Ovary Cells and Identification of Specific Polyamine Substrates J. Biol. Chem., August 15, 1997; 272(33): 20484 - 20489. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |